NCT01320410View on ClinicalTrials.gov

Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Healthy

Interventions

DRUG

ISM®

All Listed Sponsors

lead

Rovi Pharmaceuticals Laboratories

INDUSTRY

NCT01320410 - Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM® | Biotech Hunter | Biotech Hunter